Aligos expands collaboration with Merck to develop oligonucleotide therapies for NASH
12 January 2022 - 2:53AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
From Apr 2023 to Apr 2024